Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide for Heart Function in T2D with Heart Failure
NCT02344641Unknown
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Jan 2015
- Primary completion
- Dec 2016
- Modality
- Peptides
01
Overview
Randomised, open-label trial of exenatide in heart failure (HF) (2 arms), sponsored by Chinese Academy of Medical Sciences. Primary endpoint: Change in plasma NT-proBNP level at 4 weeks. Status: unknown.
02
Drugs
exenatide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT02344641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02344641.